Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
about
Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele.Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain siteEffects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice.Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress.Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles.Early gestation chorionic villi-derived stromal cells for fetal tissue engineeringConcomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons.Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injuryBrain distribution and elimination of recombinant human TIMP-1 after cerebral ischemia and reperfusion in rats.Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke.Fetal hypoxia and programming of matrix metalloproteinases.Spinal Glia Division Contributes to Conditioning Lesion-Induced Axon Regeneration Into the Injured Spinal Cord: Potential Role of Cyclic AMP-Induced Tissue Inhibitor of Metalloproteinase-1Matrix metalloproteinase-9 contributes to parenchymal hemorrhage and necrosis in the remnant liver after extended hepatectomy in miceA novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic strokeTIMP-1 attenuates blood-brain barrier permeability in mice with acute liver failure.Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantationDevelopment of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection.Neurovascular matrix metalloproteinases and the blood-brain barrier.Progranulin, a major secreted protein of mouse adipose-derived stem cells, inhibits light-induced retinal degeneration.Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.Blood-brain barrier pathophysiology in traumatic brain injury.Breaking the barrier in stroke: what should we know? A mini-review.TIMP-1 polymorphisms in a Chinese Han population with intracerebral hemorrhage.Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury.MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.Effect of Low-Dose Alcohol Consumption on Inflammation Following Transient Focal Cerebral Ischemia in Rats.Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cerebral infarction following urokinase thrombolysis in rats.Protective effect of carbamazepine on kainic acid-induced neuronal cell death through activation of signal transducer and activator of transcription-3.Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.Scutellaria baicalensis attenuates blood-brain barrier disruption after intracerebral hemorrhage in rats.Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease.
P2860
Q27301172-755D6D83-DFB0-4CB6-95C5-1B8FD762CA19Q27306345-58A15254-1B5F-4CE6-9983-834BAC0A4BA8Q33702239-66911936-0921-4BE9-90DC-46FED9BFF6AEQ33883174-AFCB17A4-C9CB-4329-9C1F-87BA3862AEC1Q34904038-46D49A5E-D4FA-4687-9B2F-BE458972CF49Q34992001-5028F262-9B49-4EA7-BD6E-BC49AC54EB8EQ35082408-42D40805-DFAB-4117-903D-B3D1F3140B22Q35146718-67F2EC19-5626-4DCA-9E97-ECBC11E10B53Q35296473-1780A1CF-48C7-43CD-A193-315AE5399459Q35354948-89F2C904-C9B0-4A19-9052-681D7923B7B3Q35552443-6F846870-48A1-4E74-BC9F-8FB35566537EQ35643324-39B77D79-999C-4801-ADC2-44E74A6703FAQ35748916-B8DFEC34-96E2-445B-B911-CB540B783282Q35963714-4BA01086-CE3B-4A92-8DC2-AB2AAAD7C404Q36147318-33C05DAA-BFF2-47D5-A918-40F32DE07B1BQ36604205-723D3863-7F2B-42DC-95B6-78E27614BAE2Q36736442-06ED2324-0B31-4B9A-A128-2F2452971286Q36750801-D46809F8-0494-4283-A25F-7354F59A29BDQ36994312-12237DE8-7E29-4BD8-BCBE-496543DFA503Q37125914-4C2B08EA-E90A-4833-B809-8BE4CF8C1108Q37234713-FE5F947F-B59F-41A7-A0A1-203EF0C0A7EDQ37270697-EC043153-D8A1-44EC-B34E-5989DCBC571DQ37516468-D4EE54F6-3780-4439-9A57-AC86DC8EB591Q37568882-CEED5436-15B6-42F1-8D26-BFBBD260CC60Q37980746-8BFC3A7F-9A0A-4EDC-8F54-225C93CD613BQ38009070-81092176-1432-4150-9DF3-CF9CD5B227C2Q38120572-8FDA734E-04B3-4DBF-B0BA-13437E9FD46DQ38196884-2FF1E651-CD43-4FCB-8205-3EAC3F3400FEQ38215270-1611A884-3E7D-4B40-A459-18FC5EBB5F9EQ38622769-BF21FE5C-41A7-4B0F-8282-845A6935EE98Q42285996-01BDB78C-D912-483F-B199-731E96DFE8DCQ43121582-EAA4A74A-A297-4D06-BCDB-9E08F9E7E43FQ43439841-F261D68C-3D15-435A-B181-D144CDF110AFQ47980596-9B7C1B12-9D6E-488F-A814-A0FB167E7A47Q48680615-726D9BDF-FAB6-41A0-A817-6E600272CF4CQ49700133-10981F4F-3569-493D-93A7-A10BE5912E22Q49829727-A72E24D0-3066-48EC-A4B4-061D6798B56F
P2860
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
@ast
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
@en
type
label
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
@ast
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
@en
prefLabel
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
@ast
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
@en
P2093
P2860
P356
P1476
Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
@en
P2093
Anna Rosell
Emiri Tejima
Josephine Lok
Klaus van Leyen
Shuzhen Guo
Xiaoying Wang
Yoshihiro Murata
P2860
P304
P356
10.1089/NEU.2009.0959
P577
2009-11-01T00:00:00Z